A Single-Dose Study of MK-8351 in a Lung Allergen Challenge (MK-8351-003)

Condition:   Asthma
Interventions:   Drug: Low-Dose MK-8351;   Drug: High-Dose MK-8351;   Drug: Placebo to MK-8351
Sponsors:   Merck;   Merck
Not yet recruiting – verified August 2013

View full post on ClinicalTrials.gov: asthma | received in the last 14 days